1. Pink Sheet
  2. >>Geography
  3. >>Europe

EMA To Clarify Member State-Specific Requirements For New EudraVigilance System

 
• By Neena Brizmohun

Drug makers preparing for the launch of the enhanced EudraVigilance database in the EU will soon be told about any plans, arrangements and requirements that are specific to the national competent authorities.

European Union
Companies will learn about member state-specific Eudravigilance requirements • Source: Shutterstock

Europe’s enhanced EudraVigilance database for managing and analyzing suspected adverse reactions to authorized medicines is still on track to go live on Nov. 22, and drug companies should in September learn about any specific requirements the national competent authorities (NCAs) might have.

Marketing authorization holders (MAHs) and clinical trial sponsors will be given information on such things as the use of local...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

US FDA’s Elsa AI Platform Is Not Guiding Regulatory Decisions, Official Says

 
• By Cathy Kelly

Tala Fakhouri said the agency’s use of the AI tool in the review process has generated lots of questions.

Branch Chief Vijay Kumar Named Acting Head Of US FDA’s Cell, Gene Therapy Office

 
• By Derrick Gingery

Kumar takes over as acting director of the Center for Biologics Evaluation and Research’s Office of Therapeutic Products days after director Nicole Verdun was ousted.

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.